학술논문
1113P Real-world multicentre cohort of 1L pembrolizumab alone or in combination with platinum-based chemotherapy in NSCLC PD-L1 ≥ 50%
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1060-S1060
Subject
Language
ISSN
0923-7534